Home » Topics » Regulatory

Regulatory
RSS

New higher dose formulations of Diovan HCT approved

May 5, 2006

Dacogen approved for myelodysplastic syndromes

May 4, 2006

European approval for Preotact

April 27, 2006

Feron approved in Japan for compensatory cirrhosis C

April 21, 2006

Pramipexole approved in Europe for restless legs syndrome

April 10, 2006

Myozyme approved for Pompe disease in Europe

April 4, 2006

Relenza approved for prophylactic use, GSK advances pandemic flu vaccines

April 3, 2006

Korean approval for Quinvaxem pentavalent vaccine

March 29, 2006

Aranesp approved for every-three-week dosing

March 28, 2006

Lyrica receives European approval for GAD

March 28, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.